Novel genetics, pathobiology & therapy of nephronophthisis-related ciliopathies
新遗传学、病理学
基本信息
- 批准号:8067119
- 负责人:
- 金额:$ 30.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAnimal ModelAwardBlindnessCell CycleCell Cycle RegulationCell PolarityCentrosomeCharacteristicsChronic Kidney FailureCiliaCystic Kidney DiseasesDataDegenerative DisorderDevelopmentDiseaseDisease modelDysplasiaEsthesiaEvolutionFamilyGene MutationGenesGeneticGenotypeHeartHormonalHumanIndividualKidney FailureLarge-Scale SequencingLifeLiver FibrosisMaintenanceMapsMental RetardationMissense MutationMitotic spindleModelingMorphogenesisMusMutateMutationNephronophthisisOrganOrganellesOrganismPathogenesisPharmaceutical PreparationsPhenotypePremature aging syndromeProteinsRetinalRetinal DegenerationSensorySignal PathwaySignal TransductionSyndromeTestingTherapeuticTissuesZebrafishanimal model developmentbonebrain malformationcell typeciliopathycohortdisease phenotypedrug candidatedrug testingearly onsetexomehuman diseaseinsightloss of functionmalformationnovelnovel therapeutic interventionpleiotropismprotein complexprotein protein interactionpublic health relevancerepairedsmoothened signaling pathway
项目摘要
DESCRIPTION (provided by applicant): Nephronophthisis (NPHP) is a monogenic recessive cystic kidney disease that represents the most frequent genetic cause of kidney failure in the first 30 years of life. It can be associated with progressive blindness (retinal degeneration), liver fibrosis, mental retardation and malformations of brain, heart and bone. By homozygosity mapping we have previously identified recessive mutations in 4 genes (NPHP1-4) as the cause of NPHP with retinal involvement. Within the preceding award we identified and characterized 5 additional NPHP-causing genes (NPHP5-9) and generated disease models in mouse and zebrafish. The data helped define a unifying pathogenic concept for the new disease entity of "ciliopathies", which represent genetic defects in functional components of primary cilia (PC). PC are sensory organelles expressed by virtually all vertebrate cell types. PC are utilized across evolution, from single cellular organisms to humans, for cellular sensory tasks, including photo-, mechano-, thermo-, olfactory, and hormonal sensation. By identification of the NPHP1-9 genes we implicated non-canonical Wnt signaling, hedgehog signaling, and cell cycle regulation in the pathogenesis of cystic kidney diseases. In addition, we demonstrated that specific mutated alleles determine the disease phenotype of NPHP-related ciliopathies in the following way: Two truncating mutations cause a severe, early- onset developmental phenotype that affects morphogenesis and leads to malformation or dysplasia (Meckel- Gruber syndrome), whereas two missense mutations cause only a mild, late-onset mature tissue phenotype that affects tissue maintenance and repair and leads to degeneration and premature ageing of organs (Senior- Loken syndrome). We demonstrate in a worldwide cohort of 1,500 families with NPHP-related ciliopathies that mutations in NPHP1-9 only explain 30% of all cases and that many additional disease causing genes must exist. To discover new ciliopathy genes and the associated signaling mechanisms, and to generate animal models and therapeutic options, we propose to: 1. Identify and functionally characterize novel genes that cause NPHP-related ciliopathies, if mutated. 2. Functionally characterize novel ciliopathy genes and determine genotype-phenotype correlations. 3. Use zebrafish models to study the function of novel genes identified and to test new drugs.
PUBLIC HEALTH RELEVANCE: Nephronophthisis (NPHP), a genetic cause of chronic kidney disease, is associated with blindness, liver fibrosis, and organ malformations. No specific treatment is available. Previous gene identification helped define the new disease group of "ciliopathies," caused by loss of function of primary cilia, which are sensory organelles important for photo-, mechano-, and olfactory sensation and for tissue development and repair. Identification of novel NPHP-related ciliopathy genes will provide further insights into disease mechanisms of dysplastic and degenerative diseases of multiple organs. It will allow development of animal models and novel therapeutic approaches to these degenerative diseases.
描述(由申请人提供):肾植物(NPHP)是一种单身性隐性囊性肾脏疾病,代表了生命的头30年中肾衰竭最常见的遗传原因。它可能与进行性失明(视网膜变性),肝纤维化,智力低下和大脑,心脏和骨骼的畸形有关。通过纯合性映射,我们以前已经确定了4个基因(NPHP1-4)中隐性突变为视网膜受累的NPHP的原因。在上一项奖项中,我们确定并表征了5个其他引起NPHP的基因(NPHP5-9),并在小鼠和斑马鱼中产生的疾病模型。该数据有助于为“纤毛病”的新疾病实体定义了一个统一的致病概念,该疾病代表原发性纤毛(PC)功能成分的遗传缺陷。 PC是几乎所有脊椎动物细胞类型表达的感觉细胞器。 PC在进化中被用于从单个细胞生物到人类,用于细胞感觉任务,包括光,机械,热,嗅觉和激素感觉。通过鉴定NPHP1-9基因,我们与囊性肾脏疾病的发病机理中有关非经典Wnt信号传导,刺猬信号传导和细胞周期调节。此外,我们证明了特定的突变等位基因通过以下方式决定了与NPHP相关的纤毛病的疾病表型:两个截短突变导致严重的,早期发作的发育表型,影响形态发生并影响形态发生并导致畸形或发育不良(麦克氏 - 格鲁伯综合症),并导致两种疾病的疾病,而后期的疾病是一种疾病,结局是一种疾病,概念的现实 - 概念概念,概念概念,造成了现实,并引起了疾病的现象,并导致了现实的现实,并导致了畸形或增生。维护和维修,并导致器官(高级综合症)的变性和过早衰老。我们在全球1,500个与NPHP相关的纤毛病的家庭中证明,NPHP1-9中的突变仅解释了所有病例中的30%,并且必须存在许多其他引起基因的疾病。为了发现新的纤毛病基因和相关的信号传导机制,并生成动物模型和治疗选择,我们建议:1。识别并在功能上表征引起NPHP相关的纤毛病的新型基因,如果突变。 2。在功能上表征了新型的纤毛病基因并确定基因型 - 表型相关性。 3。使用斑马鱼模型研究已鉴定出的新型基因的功能并测试新药。
公共卫生相关性:肾植物(NPHP)是慢性肾脏疾病的遗传原因,与失明,肝纤维化和器官畸形有关。没有特定的治疗方法。先前的基因鉴定有助于定义新的“纤毛病”疾病组,这是由于原发性纤毛功能的丧失而引起的,这对于光,机械和嗅觉感觉以及组织的发育和修复至关重要。新型NPHP相关的纤毛病基因的鉴定将为多个器官的发育异常和退化性疾病的疾病机制提供进一步的见解。它将允许开发动物模型和新的治疗方法来解决这些退化性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRIEDHELM HILDEBRANDT其他文献
FRIEDHELM HILDEBRANDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRIEDHELM HILDEBRANDT', 18)}}的其他基金
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
整合大规模基因组学和功能研究以加速 FSGS/NS 发现
- 批准号:
10047547 - 财政年份:2020
- 资助金额:
$ 30.82万 - 项目类别:
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
整合大规模基因组学和功能研究以加速 FSGS/NS 发现
- 批准号:
10441350 - 财政年份:2020
- 资助金额:
$ 30.82万 - 项目类别:
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
整合大规模基因组学和功能研究以加速 FSGS/NS 发现
- 批准号:
10237944 - 财政年份:2020
- 资助金额:
$ 30.82万 - 项目类别:
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
整合大规模基因组学和功能研究以加速 FSGS/NS 发现
- 批准号:
10652318 - 财政年份:2020
- 资助金额:
$ 30.82万 - 项目类别:
New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT)
先天性肾脏异常(CAKUT)的新基因和病理机制
- 批准号:
8318885 - 财政年份:2010
- 资助金额:
$ 30.82万 - 项目类别:
New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT)
先天性肾脏异常(CAKUT)的新基因和病理机制
- 批准号:
8630181 - 财政年份:2010
- 资助金额:
$ 30.82万 - 项目类别:
New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT)
先天性肾脏异常(CAKUT)的新基因和病理机制
- 批准号:
8105180 - 财政年份:2010
- 资助金额:
$ 30.82万 - 项目类别:
New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT)
先天性肾脏异常(CAKUT)的新基因和病理机制
- 批准号:
7940309 - 财政年份:2010
- 资助金额:
$ 30.82万 - 项目类别:
New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT)
先天性肾脏异常(CAKUT)的新基因和病理机制
- 批准号:
8507725 - 财政年份:2010
- 资助金额:
$ 30.82万 - 项目类别:
Exon capture and large-scale sequencing for disease-cause identification, early d
外显子捕获和大规模测序用于疾病原因识别、早期诊断
- 批准号:
7819207 - 财政年份:2009
- 资助金额:
$ 30.82万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 30.82万 - 项目类别:
Project 3: Therapeutic Gene Editing for Huntington's Disease
项目3:亨廷顿病的治疗性基因编辑
- 批准号:
10668769 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Genetic and Functional Mechanisms in Citrate Transporter Disorder associated with SLC13A5
与 SLC13A5 相关的柠檬酸转运蛋白紊乱的遗传和功能机制
- 批准号:
10651203 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
揭示 MS4A 基因家族在阿尔茨海默病中的作用
- 批准号:
10751885 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别: